A detailed history of Srs Capital Advisors, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 152 shares of CTLT stock, worth $9,648. This represents 0.0% of its overall portfolio holdings.

Number of Shares
152
Previous 80 90.0%
Holding current value
$9,648
Previous $4,000 125.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$56.16 - $60.96 $4,043 - $4,389
72 Added 90.0%
152 $9,000
Q2 2024

Aug 06, 2024

BUY
$53.58 - $57.02 $4,286 - $4,561
80 New
80 $4,000
Q3 2023

Nov 14, 2023

BUY
$44.2 - $50.2 $884 - $1,004
20 New
20 $0

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.